These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 204178)

  • 1. Herpes type-2 virus antibody status in groups of patients with neoplasm in Ibadan.
    Adelusi B; Osunkoya BO; Fabiyi A
    Afr J Med Med Sci; 1976 Dec; 5(4):297-301. PubMed ID: 204178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sero-epidemiology of herpes type-2 virus and carcinoma of the cervix in Ibadan.
    Adelusi B; Osunkoya BO; Fabiyi A
    Afr J Med Med Sci; 1977 Jun; 6(2):95-102. PubMed ID: 416672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus type 2 and carcinoma of cervix uteri.
    Vardthananusara C; Wasi C; Usavajindawatn C; Thongchareon P
    J Med Assoc Thai; 1978 Jan; 61(1):14-9. PubMed ID: 204721
    [No Abstract]   [Full Text] [Related]  

  • 4. Herpes simplex virus type-specific antibodies detected by indirect and competition ELISA. Comparison of sera from patients with carcinoma of the uterine cervix, age matched controls and patients with recurrent genital herpes.
    Najem SN; Vestergaard BF; Potter CW
    Acta Pathol Microbiol Immunol Scand B; 1983 Jun; 91(3):205-7. PubMed ID: 6308950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reaction of antigens isolated from herpes simplex virus-transformed cells with sera of squamous cell carcinoma patients.
    Notter MF; Docherty JJ
    Cancer Res; 1976 Dec; 36(12):4394-401. PubMed ID: 187320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to herpes simplex virus types 1 and 2: a comparative study using indirect haemagglutination in carcinoma of the cervix and in other malignant conditions.
    Freymuth F; Morel C; Longson A; Tanguy M
    Biomedicine; 1975 Sep; 23(7):271-5. PubMed ID: 182291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of HSV-2-induced early antigen with antibodies from cervical carcinoma patients].
    Jiang JW
    Zhonghua Fu Chan Ke Za Zhi; 1986 Mar; 21(2):107-9, 126. PubMed ID: 3017644
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibodies to herpesvirus type 2 in carcinoma of the cervix uteri in Ibadan, Nigeria.
    Adelusi B; Osunkoya BO; Fabiyi A
    Am J Obstet Gynecol; 1975 Dec; 123(7):758-61. PubMed ID: 1106197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex virus II antigen in adenocarcinoma of the uterine cervix.
    Bhatia A; Ashokraj G
    Indian J Pathol Microbiol; 1988 Apr; 31(2):40-4. PubMed ID: 2844663
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of RNA complementary to herpes simplex virus DNA in human cervical squamous cell neoplasms.
    Eglin RP; Sharp F; MacLean AB; Macnab JC; Clements JB; Wilkie NM
    Cancer Res; 1981 Sep; 41(9 Pt 1):3597-603. PubMed ID: 6167349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.
    Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P
    J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody to herpes simplex virus type 2-induced early antigens and its radioimmunoassay with sera of cervical carcinoma patients.
    Ito H; Kurihara S; Nishimura C
    Kitasato Arch Exp Med; 1978 Jun; 51(1-2):1-13. PubMed ID: 225600
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo and in vitro measurements of the relationship of human squamous carcinomas to herpes simplex virus tumor-associated antigens.
    Hollinshead AC; Chretien PB; Lee OB; Tarpley JL; Kerney SE; Silverman NA; Alexander JC
    Cancer Res; 1976 Feb; 36(2 pt 2):821-8. PubMed ID: 56226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of herpes simplex virus antigen in human cervical carcinoma tissue].
    Xu ZH
    Zhonghua Fu Chan Ke Za Zhi; 1986 Jul; 21(4):238-41, 254. PubMed ID: 3021401
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serological aspects of the relation between herpes virus and cervico-uterine cancer].
    Suárez M; Del Campo G; Ojeda JM
    Rev Chil Obstet Ginecol; 1983; 48(1):11-5. PubMed ID: 6099904
    [No Abstract]   [Full Text] [Related]  

  • 16. Herpes type-2 viruses and gynaecological malignancies.
    Adelusi B; Fabiyi A; Osunkoya BO
    Int J Gynaecol Obstet; 1976; 14(3):209-12. PubMed ID: 13005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virions and antigens of herpes virus type 2 in cervical carcinoma.
    Aurelian L
    Cancer Res; 1973 Jun; 33(6):1539-47. PubMed ID: 4352393
    [No Abstract]   [Full Text] [Related]  

  • 18. [Herpes simplex virus type 2 antibodies in the husbans of women with cervical cancer].
    Kunkel M; Oberender H; Rätz KH; Hofmann R; Gärtner L; Heise H
    Z Gesamte Hyg; 1979 Aug; 25(8):597-9. PubMed ID: 228506
    [No Abstract]   [Full Text] [Related]  

  • 19. Herpes simplex virus antibody in south Indian patients with carcinoma cervix.
    Seshadri L; Seth P; Walter A; Seshadri MS; John TJ
    Indian J Med Res; 1984 Jan; 79():13-8. PubMed ID: 6327511
    [No Abstract]   [Full Text] [Related]  

  • 20. Possible role of Herpesvirus hominis, type 2, in human cervical cancer.
    Aurelian L
    Fed Proc; 1972; 31(6):1651-9. PubMed ID: 4351374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.